ProQR Therapeutics (PRQR) Cash & Equivalents Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | -32.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32.62% |
| Dec 31, 2024 | 24.77% |
| Dec 31, 2023 | 32.33% |
| Sep 30, 2023 | -30.59% |
| Jun 30, 2023 | -16.12% |
| Mar 31, 2023 | -29.12% |
| Dec 31, 2022 | -54.93% |
| Sep 30, 2022 | 14.98% |
| Jun 30, 2022 | 82.73% |
| Mar 31, 2022 | 130.07% |
| Dec 31, 2021 | 137.25% |
| Sep 30, 2021 | 25.75% |
| Jun 30, 2021 | -25.93% |
| Mar 31, 2021 | -99.93% |
| Dec 31, 2020 | -27.03% |
| Sep 30, 2020 | 11.31% |
| Jun 30, 2020 | 3.94% |
| Mar 31, 2020 | 102,883.78% |
| Dec 31, 2019 | 2.83% |
| Sep 30, 2019 | 109.99% |
| Jun 30, 2019 | 106.67% |
| Mar 31, 2019 | -100.00% |
| Dec 31, 2018 | 112.79% |
| Sep 30, 2018 | -100.00% |
| Jun 30, 2018 | 88,186,342.28% |
| Mar 31, 2018 | 93,688,349,333.65% |
| Dec 31, 2017 | -11.40% |
| Sep 30, 2017 | 95,997,909,128.97% |
| Dec 31, 2016 | -38.53% |
| Sep 30, 2016 | -100.00% |
| Dec 31, 2015 | -26.20% |
| Sep 30, 2015 | 247,259.50% |
| Mar 31, 2015 | 2,172.65% |
| Dec 31, 2014 | 2,407.17% |
| Sep 30, 2014 | 1,338.81% |